Literature DB >> 31200613

Decisions in the Psychology of Glucose Monitoring.

Gérard Reach1.   

Abstract

This commentary aims to discuss the parallels between nonadherence to continuous glucose level monitoring and nonadherence to medication in people with diabetes and to investigate specific reasons for the difficulties involved in glucose monitoring. To this end, examples are given from both continuous and discontinuous glucose monitoring (CGM and SMBG, respectively).

Entities:  

Keywords:  CGM; SMBG; adherence; glucose monitoring; medication

Mesh：

Substances：

Year:  2019        PMID： 31200613      PMCID： PMC6835178          DOI： 10.1177/1932296819854109

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


  38 in total

1.  Skin and adhesive issues with continuous glucose monitors: a sticky situation.

Authors:  Kimberly Englert; Katrina Ruedy; Julie Coffey; Kimberly Caswell; Amy Steffen; Lucy Levandoski
Journal:  J Diabetes Sci Technol       Date:  2014-04-24

2.  Limitations of Continuous Glucose Monitor Usage.

Authors:  Henry Anhalt
Journal:  Diabetes Technol Ther       Date:  2016-03       Impact factor: 6.118

Review 3.  Temporality in chronic diseases and adherence to long-term therapies: From philosophy to science and back.

Authors:  G Reach
Journal:  Diabetes Metab       Date:  2018-11-22       Impact factor: 6.041

4.  Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge medications.

Authors:  Lee A Lindquist; Lise Go; Jori Fleisher; Nelia Jain; Elisha Friesema; David W Baker
Journal:  J Gen Intern Med       Date:  2011-10-05       Impact factor: 5.128

Review 5.  A new taxonomy for describing and defining adherence to medications.

Authors:  Bernard Vrijens; Sabina De Geest; Dyfrig A Hughes; Kardas Przemyslaw; Jenny Demonceau; Todd Ruppar; Fabienne Dobbels; Emily Fargher; Valerie Morrison; Pawel Lewek; Michal Matyjaszczyk; Comfort Mshelia; Wendy Clyne; Jeffrey K Aronson; J Urquhart
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 6.  Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.

Authors:  Gregory P Forlenza; Laurel H Messer; Cari Berget; R Paul Wadwa; Kimberly A Driscoll
Journal:  Curr Diab Rep       Date:  2018-09-26       Impact factor: 4.810

7.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

8.  Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.

Authors:  Andrew J Farmer; Lauren R Rodgers; Mike Lonergan; Beverley Shields; Michael N Weedon; Louise Donnelly; Rury R Holman; Ewan R Pearson; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

9.  Healthcare Resource Waste Associated with Patient Nonadherence and Early Discontinuation of Traditional Continuous Glucose Monitoring in Real-World Settings: A Multicountry Analysis.

Authors:  Shengsheng Yu; Biju Varughese; Zhiyi Li; Pam R Kushner
Journal:  Diabetes Technol Ther       Date:  2018-06       Impact factor: 6.118

Review 10.  Adherence and health care costs.

Authors:  Aurel O Iuga; Maura J McGuire
Journal:  Risk Manag Healthc Policy       Date:  2014-02-20
View more
  3 in total

1.  Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes.

Authors:  David C Klonoff; Jennifer Y Zhang; Trisha Shang; Chhavi Mehta; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2020-12-08

2.  Intentionality in adherence to long-term therapies. Results from an online survey of 3,001 patients with cardio-metabolic pathologies in France.

Authors:  Gérard Reach; Laurent Benarbia; Eric Bruckert; Jean-Philippe Kevorkian; Michel Farnier; Jean-Jacques Mourad; Bernard-Charles Vaisse
Journal:  Patient Prefer Adherence       Date:  2021-08-11       Impact factor: 2.711

3.  An Unsafe/Safe Typology in People with Type 2 Diabetes: Bridging Patients' Expectations, Personality Traits, Medication Adherence, and Clinical Outcomes.

Authors:  Gérard Reach; Laurent Benarbia; Pierre-Yves Benhamou; Brigitte Delemer; Séverine Dubois; Didier Gouet; Bruno Guerci; Nathalie Jeandidier; Karim Lachgar; Gilles Le Pape; Rémy Leroy; Jean-Hugues Masgnaux; Philippe Raclet; Yves Reznik; Jean-Pierre Riveline; Pauline Schaepelynck; Anne Vambergue; Bruno Vergès
Journal:  Patient Prefer Adherence       Date:  2022-05-25       Impact factor: 2.314
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.